Skip to main content
HairCited

The Association of Serum Ferritin Levels With Non-scarring Alopecia in Women.

Muhammad Fawad Aslam, Mariam Khalid, Muhammad Amad Aslam
Other Cureus 2022 3 цитирований
PubMed DOI PDF
<\/script>\n
`; }, get iframeSnippet() { const domain = 'haircited.com'; const params = 'pmid\u003D36601197'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

Study Design

Тип исследования
Case-control
Размер выборки
100
Вмешательство
The Association of Serum Ferritin Levels With Non-scarring Alopecia in Women. None
Препарат сравнения
Placebo
Направление эффекта
Negative
Риск систематической ошибки
Moderate

Abstract

Objective We designed this study to evaluate the association of serum ferritin levels with non-scarring alopecia in women. Methodology All patients were diagnosed by performing a clinical examination of the crown part width and occiput. Ludwig's classification was used to categorize the cases into grades I-III. Different laboratory tests were performed for the baseline investigation, including serum iron, total iron-binding capacity (TIBC), hemogram, and thyroid function tests. Of the 5 ml of venous blood drawn for routine biochemical tests, 3 ml was stored at -20°C for measuring serum ferritin, while the other 2 ml was sent for a complete blood count. Student's t-test, a chi-square test, and Fisher's exact test were used for comparing the variables. Results This study recruited 100 cases of alopecia. Out of them, 46% of patients were diagnosed with alopecia areata, 25% of cases reported androgenetic alopecia, and 29% of cases of telogen effluvium were also observed. We observed overall mean serum ferritin levels of 20.47±17.50 and 27.87±17.51 in the case versus the control group with a statistically significant difference of 0.005. Conclusion Our study shows that iron stores are one of the independent hazards of alopecia in non-menopausal women. Thus, proper laboratory examination is needed to manage the disease prevalence and prognosis.

Full Text

PDF
Loading PDF...

Tables

Table 1

Variables Controls Cases P-value
Red cells
Erythrocyte sedimentation rate 9.3±3.23 10.3±4.4 0.067
Total erythrocyte count 4.19±0.46 4.21±0.50 0.748
Mean corpuscular hemoglobin (MCH) in picogram 30.25±1.56 28.85±2.27 0.001
Hemoglobin (HB) 12.84±0.96 12.39±1.40 0.011
Hematocrit (%) 40.92±2.65 38.95±4.18 0.001
Mean corpuscular hemoglobin concentration (MCHC) (g/dl) 31.81±1.57 31.35±1.80 0.072
Mean corpuscular volume (MCV)  90.81±1.79 88.67±4.15 0.001
Peripheral blood film  
Abnormal (<15%) 19% 37% 0.001
Normal (>15%) 81% 63% 0.001

Table 2

Variables N (%) Mean±SD P-value
Androgenetic alopecia 25 (25%) 15.23±9.27 0.015
Grade I androgenetic alopecia 16 (64%) 16.86±11.33 0.011
Grade II androgenetic alopecia 9 (36%) 13.59±7.73 0.017
Alopecia areata 46 (46%) 19.71±18.56 0.017
Telogen effluvium 29 (29%) 24.13±19.75 0.328
Chronic telogen effluvium 9 (31.03%) 21.86±27.76 0.346
Acute telogen effluvium 20 (68.9%) 27.57±16.89 0.945

Table 3

Parameters Case, N (%) Controls, N (%) P-value
<20 ng/ml 63 (63%) 38 (38%) 0.001
>20 ng/ml 37 (37%) 62 (62%)

Table 4

Subgroup Serum ferritin of <20 ng/ml, N (%) Serum ferritin of >20 ng/ml, N (%) P-value
Androgenetic alopecia 17 (68%) 8 (32%) 0.012
Total cases of telogen effluvium 16 (55.2%) 13 (44.8%) 0.990
Chronic telogen effluvium 7 (77.8%) 2 (22.2%) 0.031
Acute telogen effluvium 9 (45%) 11 (55%) 0.558
Alopecia areata 30 (65.2%) 16 (34.8%) 0.002

References

  1. Untitled
  2. Untitled
  3. Untitled
  4. Untitled
  5. Untitled
  6. Untitled
  7. Untitled
  8. Untitled
  9. Untitled
  10. Untitled
  11. Untitled
  12. Untitled
  13. Untitled
  14. Untitled
  15. Untitled
  16. Untitled
  17. Untitled
  18. Untitled
  19. Untitled
  20. Untitled

Used In Evidence Reviews

Similar Papers